Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influenza Vaccine Responses in the Setting of Melanoma Treatment

NCT03315975 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03315975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03315975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influenza Vaccine Responses in the Setting of Melanoma Treatment
Lead sponsor
University of Pennsylvania
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 20, 2017
Completion date
July 1, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

viral vaccines